Literature DB >> 11239718

Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.

M C Beinfeld1, K Connolly.   

Abstract

Cannabinoid use is known to disrupt learning and memory in a number of species. cholecystokinin (CCK) release and CCK receptors have been implicated in spatial memory processes in rodents. Rat hippocampal CCK interneurons express cannabinoid 1 receptors (CB1). The CB1 agonist R(+)WIN 55,212-2 (WIN+), at 1 and 10 micromol, strongly inhibited potassium-evoked CCK release from rat hippocampal slices, while the inactive isomer S(-)WIN,55,212-3 (WIN-) had no effect. CCK release from cerebral cortical slices was not altered by WIN+.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239718     DOI: 10.1016/s0304-3940(01)01591-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

Review 1.  Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years.

Authors:  Alex Straiker; Ken Mackie
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

Review 2.  An Introduction to the Endogenous Cannabinoid System.

Authors:  Hui-Chen Lu; Ken Mackie
Journal:  Biol Psychiatry       Date:  2015-10-30       Impact factor: 13.382

Review 3.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

4.  Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.

Authors:  Takako Ohno-Shosaku; Hiroshi Tsubokawa; Ichiro Mizushima; Norihide Yoneda; Andreas Zimmer; Masanobu Kano
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

5.  Gamma oscillation deficits and the onset and early progression of schizophrenia.

Authors:  Tsung-Ung W Woo; Kevin Spencer; Robert W McCarley
Journal:  Harv Rev Psychiatry       Date:  2010 May-Jun       Impact factor: 3.732

Review 6.  Role of cannabis and endocannabinoids in the genesis of schizophrenia.

Authors:  Emilio Fernandez-Espejo; Maria-Paz Viveros; Luis Núñez; Bart A Ellenbroek; Fernando Rodriguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2009-07-24       Impact factor: 4.530

7.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

8.  Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex.

Authors:  Joseph Trettel; Dale A Fortin; Eric S Levine
Journal:  J Physiol       Date:  2004-01-23       Impact factor: 5.182

9.  Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.

Authors:  Alexandre Seillier; Alex A Martinez; Andrea Giuffrida
Journal:  Neuropsychopharmacology       Date:  2013-04-05       Impact factor: 7.853

Review 10.  Endocannabinoids in the retina: from marijuana to neuroprotection.

Authors:  Stephen Yazulla
Journal:  Prog Retin Eye Res       Date:  2008-08-03       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.